Why the study?
Cardiovascular toxicity related to anticancer therapies has become a leading cause of non-cancer morbidity and mortality, necessitating a standardized framework for its management in Primary Care.
This position statement provides a standardized framework for Primary Care physicians in Spain to manage, monitor, and prevent cardiotoxicity in oncology patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pallarés-Carratalá et al. (2026) conducted a review in Cardiotoxicity in oncology patients. Comprehensive management of cardiotoxicity in Primary Care was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: